Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| CRGX | CARGO THERAPEUTICS INC | United States | $796.71M | 39,363,052 | 71.34% | 28.66% | Net Buying | |
| PYXS | PYXIS ONCOLOGY INC | United States | $254.62M | 58,133,375 | 15.13% | 36.17% | Net Selling | |
| KRRO | KORRO BIO INC | United States | $433.27M | 8,021,946 | 18.90% | 81.10% | Net Buying | Net Buying |
| MAG | MAG SILVER CORP | Canada | $1.31B | 102,972,650 | 38.42% | 0.00% | ||
| CELC | CELCUITY INC | United States | $539.02M | 30,453,120 | 52.40% | 15.32% | Net Selling | Net Selling |
| DCOM | DIME COMMUNITY BANCSHARES INC | United States | $761.86M | 38,970,051 | 75.07% | 11.67% | Net Selling | Net Selling |
| MQ | MARQETA INC | United States | $3.02B | 518,112,108 | 59.70% | 0.58% | Net Selling | Net Selling |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | United States | $1.33B | 49,778,127 | 83.80% | 16.20% | Net Buying | Net Buying |
| NKTX | NKARTA INC | United States | $336.03M | 49,416,186 | 53.86% | 46.14% | Net Buying | Net Buying |
| KURA | KURA ONCOLOGY INC | United States | $1.61B | 76,180,620 | 90.77% | 9.23% | Net Buying | |
| KD | KYNDRYL HOLDINGS INC | United States | $4.78B | 230,103,348 | 71.45% | 20.82% | Net Buying | |
| CNNE | CANNAE HOLDINGS INC | United States | $1.51B | 72,481,945 | 81.39% | 17.96% | Net Selling | Net Selling |
| HCAT | HEALTH CATALYST INC | United States | $397.06M | 58,563,005 | 74.87% | 25.13% | Net Selling | Net Selling |
| NOV | NOV INC | United States | $7.50B | 395,535,931 | 92.89% | 1.23% | Net Selling | Net Selling |
| TGI | TRIUMPH GROUP INC | United States | $1.09B | 76,866,074 | 91.99% | 8.01% | Net Selling | Net Selling |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $138.19M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| ATLX | ATLAS LITHIUM CORP | United States | $197.93M | 12,769,581 | 15.50% | 62.12% | Net Buying | Net Selling |
| DRI | DARDEN RESTAURANTS INC | United States | $17.55B | 119,358,947 | 83.41% | 16.59% | Net Selling | Net Selling |
| QCRH | QCR HOLDINGS INC | United States | $974.83M | 16,792,880 | 69.97% | 11.13% | Net Buying | Net Buying |
| LINC | LINCOLN EDUCATIONAL SERVICES CORP | United States | $374.18M | 31,443,711 | 14.86% | 85.14% | Net Selling | Net Selling |
| SKIL | SKILLSOFT CORP | United States | $59.89M | 8,093,911 | 6.93% | 93.07% | Net Selling | Net Selling |
| TPST | TEMPEST THERAPEUTICS INC | United States | $80.34M | 22,192,026 | 4.15% | 95.85% | ||
| IMAB | I-MAB | China | $146.95M | 185,613,662 | 6.65% | 0.00% | ||
| BOLD | BOUNDLESS BIO INC | United States | N/A | 22,239,333 | 0.00% | 23.98% | Net Buying | Net Buying |
| GT | GOODYEAR TIRE & RUBBER CO | United States | $3.54B | 284,687,007 | 83.91% | 1.39% | Net Selling | Net Selling |
| HDSN | HUDSON TECHNOLOGIES INC | United States | $428.71M | 45,510,925 | 48.59% | 51.41% | Net Buying | |
| ORIC | ORIC PHARMACEUTICALS INC | United States | $647.93M | 67,422,307 | 70.31% | 29.69% | Net Selling | Net Selling |
| CSGS | CSG SYSTEMS INTERNATIONAL INC | United States | $1.24B | 29,685,975 | 92.53% | 7.47% | Net Selling | Net Selling |
| LBPH | LONGBOARD PHARMACEUTICALS INC | United States | $857.11M | 38,880,054 | 42.51% | 0.08% | Net Selling | |
| ORGO | ORGANOGENESIS HOLDINGS INC | United States | $321.99M | 131,963,176 | 6.24% | 93.76% | Net Selling | Net Selling |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | United States | $1.97B | 171,320,174 | 0.00% | 100.00% | Net Buying | Net Buying |
| VRNA | VERONA PHARMA PLC | United Kingdom | $1.20B | 646,524,958 | 10.44% | 55.89% | Net Selling | Net Selling |
| KE | KIMBALL ELECTRONICS INC | United States | $551.10M | 24,869,206 | 75.85% | 6.39% | Net Selling | |
| SRRK | SCHOLAR ROCK HOLDING CORP | United States | $1.17B | 79,754,065 | 60.56% | 39.44% | Net Buying | Net Selling |
| RLAY | RELAY THERAPEUTICS INC | United States | $894.68M | 132,741,677 | 72.37% | 27.63% | Net Selling | Net Selling |
| HURN | HURON CONSULTING GROUP INC | United States | $1.58B | 18,005,790 | 82.30% | 17.70% | Net Selling | Net Selling |
| REPL | REPLIMUNE GROUP INC | United States | $422.35M | 61,387,786 | 67.71% | 32.29% | Net Selling | |
| CRGY | CRESCENT ENERGY CO | United States | $2.11B | 177,464,725 | 32.61% | 27.55% | Net Selling | Net Selling |
| GETY | GETTY IMAGES HOLDINGS INC | United States | $1.66B | 405,870,456 | 26.03% | 73.97% | Net Selling | Net Selling |
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $376.14M | 50,420,315 | 5.85% | 51.39% | Net Buying | |
| INZY | INOZYME PHARMA INC | United States | $284.54M | 61,855,509 | 54.64% | 45.36% | Net Buying | Net Selling |
| CABA | CABALETTA BIO INC | United States | $614.60M | 48,241,615 | 92.00% | 8.00% | Net Buying | |
| CIFR | CIPHER MINING INC | United States | $1.18B | 310,029,275 | 11.34% | 41.54% | Net Selling | |
| LRMR | LARIMAR THERAPEUTICS INC | United States | $518.69M | 63,800,017 | 42.05% | 57.95% | Net Buying | Net Buying |
| ALIT | ALIGHT INC | United States | $5.23B | 562,982,418 | 72.90% | 27.10% | Net Selling | Net Selling |
| PMVP | PMV PHARMACEUTICALS INC | United States | $112.15M | 51,443,488 | 62.78% | 37.22% | Net Buying | |
| VIPS | VIPSHOP HOLDINGS LTD | China | $8.49B | 108,460,605 | 100.00% | 0.00% | ||
| ENGN | ENGENE HOLDINGS INC | Canada | $650.67M | 43,581,331 | 32.55% | 27.91% | Net Buying | Net Buying |
| CWH | CAMPING WORLD HOLDINGS INC | United States | $1.72B | 84,539,022 | 44.37% | 22.04% | Net Selling | Net Selling |
| FOUR | SHIFT4 PAYMENTS INC | United States | $5.14B | 86,191,714 | 68.55% | 3.85% | Net Selling | Net Selling |
| ANGI | ANGI INC | United States | $1.30B | 501,741,855 | 12.50% | 15.18% | Net Selling | Net Selling |
| HTBK | HERITAGE COMMERCE CORP | United States | $507.71M | 61,169,473 | 73.09% | 22.15% | Net Buying | Net Buying |
| MSTR | MICROSTRATEGY INC | United States | $22.30B | 17,737,431 | 45.87% | 0.62% | Net Selling | Net Selling |
| GOSS | GOSSAMER BIO INC | United States | $165.59M | 226,218,652 | 86.47% | 13.53% | Net Buying | Net Selling |
| EWTX | EDGEWISE THERAPEUTICS INC | United States | $1.98B | 93,110,623 | 84.20% | 15.80% | Net Buying | Net Selling |
| BECN | BEACON ROOFING SUPPLY INC | United States | $5.97B | 63,599,031 | 78.84% | 21.16% | Net Selling | Net Selling |
| ANRO | ALTO NEUROSCIENCE INC | United States | $403.53M | 26,883,988 | 0.00% | 24.97% | Net Buying | Net Buying |
| IHS | IHS HOLDING LTD | United Kingdom | $1.31B | 331,920,002 | 14.21% | 0.00% | ||
| ATMU | ATMUS FILTRATION TECHNOLOGIES INC | United States | $2.47B | 83,355,930 | 32.64% | 0.59% | Net Selling | Net Selling |
| BHVN | BIOHAVEN LTD | United States | $3.38B | 81,579,914 | 79.08% | 20.92% | Net Buying | Net Buying |
| ROST | ROSS STORES INC | United States | $44.10B | 335,174,141 | 87.26% | 4.81% | Net Selling | Net Selling |
| DBRG | DIGITALBRIDGE GROUP INC | United States | $2.57B | 173,781,220 | 87.62% | 11.34% | Net Selling | Net Selling |
| SLN | SILENCE THERAPEUTICS PLC | United Kingdom | $878.19M | 118,846,966 | 17.28% | 0.00% | ||
| MGM | MGM RESORTS INTERNATIONAL | United States | $12.75B | 313,680,435 | 37.96% | 62.04% | Net Selling | Net Selling |
| CRMD | CORMEDIX INC | United States | $321.09M | 54,981,102 | 34.05% | 10.98% | Net Buying | Net Buying |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $2.25B | 251,399,871 | 35.06% | 64.94% | Net Selling | Net Selling |
| IAC | IAC INC | United States | $4.85B | 86,094,182 | 77.63% | 6.35% | Net Selling | Net Buying |
| TNYA | TENAYA THERAPEUTICS INC | United States | $361.96M | 78,516,142 | 55.16% | 44.84% | Net Buying | Net Buying |
| RCUS | ARCUS BIOSCIENCES INC | United States | $1.41B | 90,864,829 | 48.32% | 51.68% | Net Buying | Net Selling |
| NAMS | NEWAMSTERDAM PHARMA CO NV | Netherlands | $1.98B | 89,266,673 | 60.05% | 39.95% | Net Selling | Net Selling |
| CTNM | CONTINEUM THERAPEUTICS INC | United States | N/A | 27,055,790 | 0.00% | 9.96% | ||
| ABUS | ARBUTUS BIOPHARMA CORP | Canada | $535.96M | 188,717,409 | 24.75% | 75.25% | Net Selling | |
| LENZ | LENZ THERAPEUTICS INC | United States | $136.69M | 8,319,561 | 49.99% | 50.01% | Net Buying | Net Buying |
| HLVX | HILLEVAX INC | United States | $690.34M | 49,700,828 | 65.86% | 34.14% | Net Selling | Net Selling |
| MNMD | MIND MEDICINE (MINDMED) INC | Canada | $394.74M | 41,334,307 | 10.01% | 89.99% | Net Selling | Net Selling |
| VSTM | VERASTEM INC | United States | $288.87M | 25,295,495 | 25.42% | 74.58% | Net Selling | Net Selling |
| DNLI | DENALI THERAPEUTICS INC | United States | $2.40B | 142,609,036 | 56.52% | 43.48% | Net Selling | Net Selling |
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.52B | 32,460,579 | 20.77% | 79.23% | Net Buying | Net Selling |
| PRGS | PROGRESS SOFTWARE CORP | United States | $2.22B | 43,218,086 | 83.38% | 16.62% | Net Selling | Net Selling |
| PTGX | PROTAGONIST THERAPEUTICS INC | United States | $1.51B | 58,652,133 | 79.94% | 20.06% | Net Selling | Net Selling |
| INAB | IN8BIO INC | United States | $43.72M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| CNOB | CONNECTONE BANCORP INC | United States | $752.48M | 38,333,053 | 60.01% | 39.99% | Net Selling | Net Selling |
| DFLI | DRAGONFLY ENERGY HOLDINGS CORP | United States | $69.90M | 60,260,282 | 8.09% | 72.63% | ||
| NR | NEWPARK RESOURCES INC | United States | $627.94M | 85,201,652 | 80.86% | 12.01% | Net Selling | |
| CZR | CAESARS ENTERTAINMENT INC | United States | $7.87B | 216,415,536 | 78.35% | 21.65% | Net Selling | Net Buying |
| DAL | DELTA AIR LINES INC | United States | $33.69B | 645,312,283 | 69.12% | 0.37% | Net Selling | Net Selling |
| SYNA | SYNAPTICS INC | United States | $3.60B | 39,303,612 | 93.47% | 5.04% | Net Selling | Net Selling |
| EYPT | EYEPOINT PHARMACEUTICALS INC | United States | $591.49M | 49,830,792 | 20.11% | 79.89% | Net Selling | Net Buying |
| MGX | METAGENOMI INC | United States | $242.07M | 37,472,351 | 0.00% | 32.96% | Net Buying | Net Buying |
| TSHA | TAYSHA GENE THERAPIES INC | United States | $463.81M | 187,018,275 | 69.58% | 15.93% | Net Buying | |
| XNCR | XENCOR INC | United States | $1.48B | 61,120,272 | 66.74% | 33.26% | Net Buying | Net Selling |
| TCRX | TSCAN THERAPEUTICS INC | United States | $415.14M | 47,882,196 | 66.65% | 29.73% | Net Buying | |
| ACET | ADICET BIO INC | United States | $142.13M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $106.84M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| OPK | OPKO HEALTH INC | United States | $906.09M | 696,991,677 | 17.43% | 82.57% | Net Buying | Net Buying |
| KSPI | JOINT STOCK CO KASPIKZ | Kazakhstan | $22.90B | 190,008,890 | 0.09% | 0.00% | ||
| ATXS | ASTRIA THERAPEUTICS INC | United States | $547.93M | 54,903,061 | 67.13% | 25.09% | Net Buying | Net Buying |
| LXEO | LEXEO THERAPEUTICS INC | United States | $358.16M | 26,668,956 | 60.65% | 25.62% | Net Buying | |
| CUTR | CUTERA INC | United States | $54.89M | 19,960,622 | 71.44% | 28.56% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.